Adam Feuerstein, biotech reporter for STAT News, stated in a post to X: “$SLNO did not preannounce Q3 sales. That’s disappointing, as much as disclosure of preliminary Vykat XR sales for Q3 was a possibility to counter the bear thesis. Looks like we need to wait for the scheduled earnings report on Nov. 4.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO: